The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market. The report segments the market for IVD analyzers based on analyzer type, level of automation, design, therapeutic area, and end user. The market is segmented into immunoassay analyzers, clinical chemistry, hematology and coagulation, molecular diagnostics, PoC analyzers and others based on test type. Based on level of automation, analyzers are categorized into semi-automated and fully automated. Based on therapeutic area, the market is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. The market is segmented into diagnostic centers, hospitals and clinics, research institutions and others based on end user. The report includes profiles of the leading companies with information about their business segments, financials, product portfolios, and recent developments.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). The North America region includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., France, and the rest of Europe. The Asia-Pacific region includes China, India, Japan, and the rest of Asia-Pacific.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). The North America region includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., France, and the rest of Europe. The Asia-Pacific region includes China, India, Japan, and the rest of Asia-Pacific.
Report Includes
- 39 data tables and 34 additional tables
- An analysis of the global market for in vitro diagnostics (IVD) analyzers
- Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
- Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19’s impact on the IVD industry
- Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies’ ESG scores, future of ESG, case studies and the ESG practices of leading companies
- Overview of the emerging new technologies and patents in the market
- Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
- Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Market Breakdown by Analyzer Type
Chapter 6 Market Breakdown by Level of Automation
Chapter 7 Market Breakdown by Therapeutic Area
Chapter 8 Market Breakdown by End User
Chapter 9 Market Breakdown by Region
Chapter 10 ESG Development
Chapter 11 Emerging Technologies and Developments
Chapter 12 Regulatory Scenario
Chapter 13 M&A Analysis
Chapter 14 Competitive Landscape
Chapter 15 Company Profiles
List of Tables
List of Figures
Executive Summary
The global market for IVD analyzers was valued at $12.2 billion in 2022, and is projected to reach $16.3 billion by the end of 2028 at a CAGR of 4.7 % during the forecast period of 2023 to 2028. The increasing elderly population, growing incidence of chronic diseases, widening use of diagnostics for prevention and monitoring, and growing adoption of PoC testing are driving market growth.Based on analyzer type, the market is categorized into immunoassay analyzers, clinical chemistry analyzers, hematology and hemostasis analyzers, molecular diagnostic analyzers and PoC analyzers. The molecular analyzers segment, which held the third largest market share in 2022, is expected to show the highest CAGR, at 6.0%, during the forecast period. This segment’s share is attributed to the growing incidence of cancer and cancer-related diseases.
The market is also segmented into semi-automated and fully automated analyzers. The semi-automated segment accounted for 67.2% of the market in 2022. The fully automated segment is expected to grow at a higher CAGR of 6.4% during the forecast period, due to an increasing focus on automated and modulator laboratories. Its market share is expected to increase to 35.5% in 2028, up from 32.8% in 2022.
Based ontherapeutic area, the market for IVD analyzers is segmented into infectious diseases, diabetes, cardiology, oncology, nephrology and others. Infectious diseases accounted for 46.25 of the market in 2022 and this segment is expected to grow at a CAGR of 4.3% during the forecast period. The diabetes segment is a distant second, with 9.7% of the market in 2022, and it is expected to grow at a CAGR of 5.8% during the forecast period.
In this report, the end users of IVD analyzers consist of diagnostic laboratories, hospitals and clinics, research institutions, and others. Diagnostic labs accounted for 52.3% of the market share in 2022, and the segment is expected to grow at a CAGR of 5.0% during the forecast period. The increasing number of large laboratory networks with advanced instruments is driving the growth of this segment.
Leading companies in the IVD analyzers market include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Beckman Coulter Diagnostics, Becton, Dickinson and Co., Bio-Rad Laboratories and Sysmex Corp.
Companies Mentioned
- Abbott Diagnostics Scarborough Inc.
- Becton, Dickinson And Co.
- Biomérieux
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- Ekf Diagnostics Holdings Plc
- F. Hoffmann-La Roche Ltd.
- Quidelortho Corp.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers Ag
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 138 |
| Published | December 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 12.9 Billion |
| Forecasted Market Value ( USD | $ 16.3 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
